Genetic Underpinnings of Ethnic Disparities in Bone Toxicities Between Hispanic and Non-Hispanic Children Treated for Acute Lymphoblastic Leukemia
Ancestry (9)
- PC1 - First significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487958.v1.p1)
- PC1 - First significant principal components from Eigenstrat analysis within each population (phv00536939.v1.p1)
- PC2 - Second significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487959.v1.p1)
- PC2 - Second significant principal components from Eigenstrat analysis within each population (phv00536940.v1.p1)
- PC3 - Third significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487960.v1.p1)
- PC3 - Third significant principal components from Eigenstrat analysis within each population (phv00536941.v1.p1)
- PC4 - Fourth significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487961.v1.p1)
- PC5 - Fifth significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487962.v1.p1)
- PC6 - Sixth significant principal components from Eigenstrat analysis within each population (EUR: 3 PCs, ASN: 1 PC, HIS: 2 PCs, AFR: 1 PC, OTH: 6 PCs) (phv00487963.v1.p1)
Demographics (5)
- age_yrs - Subject age at diagnosis (phv00487955.v1.p1)
- age_yrs - Subject age at diagnosis (phv00536936.v1.p1)
- sex - Biological sex (phv00487956.v1.p1)
- sex - Biological sex (phv00536937.v1.p1)
- SEX - Biological sex (phv00487949.v2.p1)
Race and Ethnicity (2)
- Race - Self-reported race/ethnicity (phv00487964.v1.p1)
- Race - Self-reported race/ethnicity (phv00536942.v1.p1)
Other (17)
- ANALYTE_TYPE - Analyte type of sample (phv00487967.v2.p1)
- BODY_SITE - Collection site of sample (phv00487966.v2.p1)
- cmp_btox - Status of bone toxicity (phv00487954.v1.p1)
- cmp_btox - Status of bone toxicity (phv00536935.v1.p1)
- cmp_btoxt - Time to bone toxicity (phv00487953.v1.p1)
- cmp_btoxt - Time to bone toxicity (phv00536934.v1.p1)
- COHORT - Cohort (phv00536943.v1.p1)
- CONSENT - Consent group as determined by DAC (phv00487948.v2.p1)
- finalrisk - Final risk group (phv00487957.v1.p1)
- finalrisk - Final risk group (phv00536938.v1.p1)
- IS_TUMOR - Tumor status of sample (phv00487968.v2.p1)
- SAMPLE_ID - Sample ID (phv00487965.v2.p1)
- SAMPLE_ID - Sample ID (phv00487951.v2.p1)
- SUBJECT_ID - Subject ID (phv00487952.v1.p1)
- SUBJECT_ID - Subject ID (phv00536933.v1.p1)
- SUBJECT_ID - Subject ID (phv00487947.v2.p1)
- SUBJECT_ID - Subject ID (phv00487950.v2.p1)